These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 28455242)

  • 1. The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence.
    Barnoud T; Schmidt ML; Donninger H; Clark GJ
    Cancer Lett; 2017 Aug; 400():30-36. PubMed ID: 28455242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ras Regulates Rb via NORE1A.
    Barnoud T; Donninger H; Clark GJ
    J Biol Chem; 2016 Feb; 291(6):3114-23. PubMed ID: 26677227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NORE1A is a double barreled Ras senescence effector that activates p53 and Rb.
    Donninger H; Barnoud T; Clark GJ
    Cell Cycle; 2016 Sep; 15(17):2263-4. PubMed ID: 26919075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ras regulates SCF(β-TrCP) protein activity and specificity via its effector protein NORE1A.
    Schmidt ML; Donninger H; Clark GJ
    J Biol Chem; 2014 Nov; 289(45):31102-10. PubMed ID: 25217643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NORE1A tumor suppressor candidate modulates p21CIP1 via p53.
    Calvisi DF; Donninger H; Vos MD; Birrer MJ; Gordon L; Leaner V; Clark GJ
    Cancer Res; 2009 Jun; 69(11):4629-37. PubMed ID: 19435914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2.
    Donninger H; Calvisi DF; Barnoud T; Clark J; Schmidt ML; Vos MD; Clark GJ
    J Cell Biol; 2015 Mar; 208(6):777-89. PubMed ID: 25778922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The growth and tumor suppressor NORE1A is a cytoskeletal protein that suppresses growth by inhibition of the ERK pathway.
    Moshnikova A; Frye J; Shay JW; Minna JD; Khokhlatchev AV
    J Biol Chem; 2006 Mar; 281(12):8143-52. PubMed ID: 16421102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth and tumor suppressor NORE1A is a regulatory node between Ras signaling and microtubule nucleation.
    Bee C; Moshnikova A; Mellor CD; Molloy JE; Koryakina Y; Stieglitz B; Khokhlatchev A; Herrmann C
    J Biol Chem; 2010 May; 285(21):16258-66. PubMed ID: 20339001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel type of Ras effector interaction established between tumour suppressor NORE1A and Ras switch II.
    Stieglitz B; Bee C; Schwarz D; Yildiz O; Moshnikova A; Khokhlatchev A; Herrmann C
    EMBO J; 2008 Jul; 27(14):1995-2005. PubMed ID: 18596699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nore1 and RASSF1 regulation of cell proliferation and of the MST1/2 kinases.
    Avruch J; Praskova M; Ortiz-Vega S; Liu M; Zhang XF
    Methods Enzymol; 2006; 407():290-310. PubMed ID: 16757333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered variants of the Ras effector protein RASSF5 (NORE1A) promote anticancer activities in lung adenocarcinoma.
    Singh A; Erijman A; Noronha A; Kumar H; Peleg Y; Yarden Y; Shifman JM
    J Biol Chem; 2021 Dec; 297(6):101353. PubMed ID: 34717958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-beta signaling engages an ATM-CHK2-p53-independent RAS-induced senescence and prevents malignant transformation in human mammary epithelial cells.
    Cipriano R; Kan CE; Graham J; Danielpour D; Stampfer M; Jackson MW
    Proc Natl Acad Sci U S A; 2011 May; 108(21):8668-73. PubMed ID: 21555587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential inductions of the ZEB1 transcription factor caused by mutation of Rb and then Ras proteins are required for tumor initiation and progression.
    Liu Y; Sánchez-Tilló E; Lu X; Huang L; Clem B; Telang S; Jenson AB; Cuatrecasas M; Chesney J; Postigo A; Dean DC
    J Biol Chem; 2013 Apr; 288(16):11572-80. PubMed ID: 23443660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of the LXCXE binding cleft of pRb facilitates transformation by ras in vitro but does not promote tumorigenesis in vivo.
    Talluri S; Francis SM; Dick FA
    PLoS One; 2013; 8(8):e72236. PubMed ID: 23936539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence.
    Sebastian T; Malik R; Thomas S; Sage J; Johnson PF
    EMBO J; 2005 Sep; 24(18):3301-12. PubMed ID: 16107878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic inactivation of the NORE1 gene correlates with malignant progression of colorectal tumors.
    Lee CK; Lee JH; Lee MG; Jeong SI; Ha TK; Kang MJ; Ryu BK; Hwangbo Y; Shim JJ; Jang JY; Lee KY; Kim HJ; Chi SG
    BMC Cancer; 2010 Oct; 10():577. PubMed ID: 20969767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogene-induced senescence pathways weave an intricate tapestry.
    Yaswen P; Campisi J
    Cell; 2007 Jan; 128(2):233-4. PubMed ID: 17254959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ras signaling through RASSF proteins.
    Donninger H; Schmidt ML; Mezzanotte J; Barnoud T; Clark GJ
    Semin Cell Dev Biol; 2016 Oct; 58():86-95. PubMed ID: 27288568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRAK is essential for ras-induced senescence and tumor suppression.
    Sun P; Yoshizuka N; New L; Moser BA; Li Y; Liao R; Xie C; Chen J; Deng Q; Yamout M; Dong MQ; Frangou CG; Yates JR; Wright PE; Han J
    Cell; 2007 Jan; 128(2):295-308. PubMed ID: 17254968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of cancer metabolism by oncogenes and tumor suppressors.
    Iurlaro R; León-Annicchiarico CL; Muñoz-Pinedo C
    Methods Enzymol; 2014; 542():59-80. PubMed ID: 24862260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.